SCHEMBL9700437

SCHEMBL9700437

CC(=O)CC(=O)c1ccc2ccc([S+](C)[O-])cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
CYP2A6 P11509 1/20 0.38
PTPN1 P18031 1/20 0.37
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HDAC1 Q13547 5/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9700347 0.82 RAB9A (0.39) SMN1; SMN2KDM4EHPGDPTPN1ALDH1A1
SCHEMBL9701342 0.78 GAA (0.46) SMN1; SMN2KDM4EHPGDCYP2A6ALDH1A1
SCHEMBL9699266 0.76 CYP2A6 (0.66) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1
SCHEMBL2774094 0.76 SMN1; SMN2 (0.72) SMN1; SMN2KDM4EHPGDPTPN1ALDH1A1
SCHEMBL9700316 0.74 SMN1; SMN2 (0.47) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1
SCHEMBL9701379 0.73 CYP1A2 (0.61) SMN1; SMN2KDM4EHPGDCYP2A6ALDH1A1
SCHEMBL28482006 0.71 CYP2A6 (0.58) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1
SCHEMBL17288589 0.69 RARA (0.31) KDM4ECES2CES1
SCHEMBL11247310 0.69 ALDH1A1 (0.65) SMN1; SMN2KDM4EHPGDALDH1A1NPC1
SCHEMBL2003577 0.69 KMT2A (0.52) SMN1; SMN2KDM4EHPGDPTPN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO disclosed
US-4939138-A 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines STERLING DRUG INC. (US) 1990-07-03 US disclosed